Peptide and Anticoagulant Drugs Market 2021 Analysis May Set New Growth Story, Forecast to 2027
The global peptide and anticoagulant drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Anticoagulants are blood thinners that prevent or reduce coagulation of blood, prolonging the clotting time. These drugs are used for deep vein thrombosis, myocardial infarction, pulmonary embolism, stroke, and others. Peptides are long-chain amino acids. The major factor for the growth of the market include the increasing prevalence of chronic diseases and increasing healthcare expenditure.
According to the Centers for
Medicare & Medicaid Services (CMS), in 2020, the US health care spending
grew 9.7%, reaching $4.1 trillion and a total of $12,530 per person.
Additionally, healthcare spending accounted for 19.7% of the nation's Gross
Domestic Product (GDP). Furthermore, according to World Health Organization
(WHO), the global healthcare expenditure was 9.8% of the world’s GDP in 2018.
Further, according to the National Center for Biotechnology Information (NCBI),
approximately one in three of all adults suffer from multiple chronic
conditions globally in 2018. Moreover, the rising geriatric population is also
driving the growth of the market.
To Request a Sample of our Report on Peptide and
Anticoagulant Drugs Market: https://www.omrglobal.com/request-sample/peptide-and-anticoagulant-drugs-market
Some major players in the market include Abbott
Laboratories, Johnson & Johnson Services, Inc., Bayer AG, and Pfizer Inc.,
among others. The market players are contributing significantly to the growth
of the market by the adoption of various strategies including mergers &
acquisitions, geographical expansion, partnerships and collaborations, and new
product launches, to stay competitive in the market. For instance, in December
2020, Nacto Pharma launched a Rivaroxban molecule under the brand name RPIGAT.
Rivaroxban is an anticoagulant medication used to prevent blood clots.
Market Coverage
• The
market number available for – 2020-2027
• Base
year- 2020
• Forecast
period- 2021-2027
• Segment
Covered-
·
By Product
·
By Application
• Regions
Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
•
Competitive Landscape-Abbott
Laboratories, Johnson & Johnson Services, Inc., Bayer AG, and Pfizer
Inc.,among others.
(Get 15% Discount on Buying this Report)
A
full Report of Peptide and Anticoagulant Drugs Market is Available
at: https://www.omrglobal.com/industry-reports/peptide-and-anticoagulant-drugs-market
Global Peptide and Anticoagulant Drugs Market Report
by Segment
By Product
• Hormonal
• Antibiotic
• ACE
Inhibitor
• Antifungal
• Others
By Application
• Diabetes
• Infectious
Diseases
• Cancer
• Osteoporosis
• Cardiology
• Gynecology
• Others
Global Peptide and Anticoagulant Drugs Market Report
by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment